Form D · Pharmaceuticals
Cocrystal Pharma, Inc.
Tucker, GA · CIK 0001412486
Offering snapshot reported May 2, 2017 · SEC filing
- Reported sold
- $3M Offering amount: $3M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 25, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 2, 2017 | Initial | $3,000,000 | No comparison | 3 | SEC filing |
| Sep 15, 2016 | Initial | $4,008,201 | No comparison | 4 | SEC filing |
| Mar 30, 2016 | Initial | $5,004,370 | No comparison | 12 | SEC filing |
| Jan 31, 2014 | Initial | $2,750,000 | No comparison | 8 | SEC filing |
| Jan 17, 2014 | Initial | $0 | No comparison | 23 | SEC filing |
| Nov 5, 2013 | Initial | $3,500,000 | No comparison | 22 | SEC filing |
| Sep 5, 2013 | Initial | $2,000,000 | No comparison | 1 | SEC filing |
| Apr 22, 2013 | Initial | $800,000 | No comparison | 5 | SEC filing |
| Jun 25, 2012 | Initial | $200,000 | No comparison | 2 | SEC filing |
| May 29, 2012 | Initial | $250,000 | No comparison | 1 | SEC filing |
| Apr 26, 2012 | Initial | $2,250,000 | No comparison | 10 | SEC filing |
| Apr 25, 2012 | Initial | $455,000 | No comparison | 5 | SEC filing |
| Apr 25, 2012 | Initial | $250,000 | No comparison | 1 | SEC filing |
| Apr 25, 2012 | Initial | $500,000 | No comparison | 1 | SEC filing |
| Mar 20, 2012 | Initial | $1,000,000 | No comparison | 1 | SEC filing |
| Mar 9, 2012 | Initial | $2,300,000 | No comparison | 3 | SEC filing |
| Jan 26, 2012 | Initial | $650,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-285894
Source: Form D, filed May 2, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| David S. Block | Director |
| Curtis Dale | Executive |
| Daniel Fisher | Director, Executive |
| Phillip Frost | Director |
| Jane H. Hsiao | Director |
| Brian Keller | Director, Executive |
| Roger Kornberg | Director |
| Sam Lee | Executive |
| Walt Addison Linscott | Executive |
| James Martin | Executive |
| Douglas L Mayers | Executive |
| Elliot M. Maza | Director, Executive |
| Gerald Mc Guire | Executive |
| Jeffrey A Meckler | Director, Executive |
| Christian Oertle | Executive |
| Roberto Prego Novo | Director |
| Steven D. Rubin | Director |
| Raymond F. Schinazi | Director |
| Gary Wilcox | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
1860 Montreal Road
Tucker, GA, 30084
Tucker, GA, 30084